ArticleJournal of hematology & oncology2018

DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.

Qian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.